Literature DB >> 11066074

New comprehensive denaturing-gradient-gel- electrophoresis assay for KRAS mutation detection applied to paraffin-embedded tumours.

V M Hayes1, J L Westra, E Verlind, W Bleeker, J T Plukker, R M Hofstra, C H Buys.   

Abstract

A comprehensive mutation detection assay is presented for the entire coding region and all splice site junctions of the KRAS oncogene. The assay is based on denaturing gradient gel electrophoresis and applicable to archival paraffin-embedded tumour material. All KRAS amplicons are analysed within two lanes of a DGGE gel under a single set of experimental conditions. Six known codon 12 mutations in genomic DNA from different paraffin-embedded tumours could readily be detected. When testing 35 paraffin-embedded Dukes' C colorectal carcinomas for unknown mutations, 12 tumours were found with mutations in codons 12 or 13. None of the tumours appeared to have a codon 61 mutation. In nine tumours, however, 11 additional sequence variations were found outside the hot-spot codons. None of these occurred in germline DNA from 57 individuals. Of these variations, three are considered as significant mutations, as they result in a non-conservative substitution of amino acid residues essential for the functioning of the KRAS protein. Thus, in total, 15 of the 35 Dukes' C tumours (43%) had a KRAS mutation of functional significance. Moreover, a novel exon 4B polymorphism was found to occur in 10 of the 35 tumours. The results of this study suggest that in restricting analysis of KRAS to hot-spot mutation sites only, significant information may be missed. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11066074

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

Review 1.  KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program.

Authors:  J H J M van Krieken; A Jung; T Kirchner; F Carneiro; R Seruca; F T Bosman; P Quirke; J F Fléjou; T Plato Hansen; G de Hertogh; P Jares; C Langner; G Hoefler; M Ligtenberg; D Tiniakos; S Tejpar; G Bevilacqua; A Ensari
Journal:  Virchows Arch       Date:  2008-09-18       Impact factor: 4.064

Review 2.  Current companion diagnostics in advanced colorectal cancer; getting a bigger and better piece of the pie.

Authors:  Jonathan M Loree; Scott Kopetz; Kanwal P S Raghav
Journal:  J Gastrointest Oncol       Date:  2017-02

Review 3.  Multiple mutations in the Kras gene in colorectal cancer: review of the literature with two case reports.

Authors:  Mariana Petaccia Macedo; Louise De Brot Andrade; Renata Coudry; Rodrigo Crespo; Marina Gomes; Bianca Cristina Garcia Lisboa; Samuel Aguiar; Fernando Augusto Soares; Dirce Maria Carraro; Isabela Werneck Cunha
Journal:  Int J Colorectal Dis       Date:  2011-05-21       Impact factor: 2.571

4.  Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.

Authors:  Hong Shen; Ying Yuan; Han-Guang Hu; Xian Zhong; Xiao-Xian Ye; Mo-Dan Li; Wei-Jia Fang; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

5.  Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue.

Authors:  Yohei Miyamae; Kimihiro Shimizu; Yasumasa Mitani; Takuya Araki; Yuki Kawai; Masaru Baba; Seiichi Kakegawa; Masayuki Sugano; Kyoichi Kaira; Alexander Lezhava; Yoshihide Hayashizaki; Koujirou Yamamoto; Izumi Takeyoshi
Journal:  J Mol Diagn       Date:  2010-01-21       Impact factor: 5.568

6.  KRAS Testing: A Tool for the Implementation of Personalized Medicine.

Authors:  Rodney E Shackelford; Nicholas A Whitling; Patricia McNab; Shanker Japa; Domenico Coppola
Journal:  Genes Cancer       Date:  2012-07

7.  A comparison of Direct sequencing, Pyrosequencing, High resolution melting analysis, TheraScreen DxS, and the K-ras StripAssay for detecting KRAS mutations in non small cell lung carcinomas.

Authors:  Sylwia Jancik; Jiri Drabek; Jitka Berkovcova; Yong Zhong Xu; Marcela Stankova; Jiri Klein; Vitezslav Kolek; Josef Skarda; Tomas Tichy; Ivona Grygarkova; Danuta Radzioch; Marian Hajduch
Journal:  J Exp Clin Cancer Res       Date:  2012-09-20

8.  Spectrum of K ras mutations in Pakistani colorectal cancer patients.

Authors:  B N Murtaza; A Bibi; M U Rashid; Y I Khan; M S Chaudri; A R Shakoori
Journal:  Braz J Med Biol Res       Date:  2013-11-29       Impact factor: 2.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.